A carregar...
Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients
Gefitinib, an inhibitor of the epidermal growth factor receptor (EGFR, HER1/ErbB1) tyrosine kinase, has been shown to have clinical activity against non-small-cell lung cancers (NSCLCs), especially in women nonsmokers with adenocarcinomas. The aim of the present study was to clarify the relationship...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361759/ https://ncbi.nlm.nih.gov/pubmed/15870715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602585 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|